Defining and Evaluating HIV-Related Neurodegenerative Disease and Its Treatment Targets: A Combinatorial Approach to Use of Cerebrospinal Fluid Molecular Biomarkers
Magnus Gisslén(Public Health Agency of Sweden), Richard W. Price(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Lars Rosengren(Sahlgrenska University Hospital), Bruce J. Brew(UNSW Sydney), Lars Hagberg(Sahlgrenska University Hospital), Serena Spudich(Yale University), Paola Cinque(University of California San Diego)
Cited by 48
Related Papers
Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease
|New England Journal of Medicine|1999|1.4k
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
|JAMA Neurology|2020|941
Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status
|Annals of Neurology|1991|572
Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF
|Journal of Neurochemistry|1996|502